pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

DECEMBER 16, 2020

Soon the ABPI and the entire industry were facing the ripple effects of COVID-19, including a significant slowdown in non-COVID clinical research, which Torbett says was challenging for the industry to deal with. “We’ve We had companies collaborating to develop laboratories. A collaborative future.

Vaccine 122

Vaccine Vaccination Life Science In-Vitro 122

pharmaphorum

MARCH 2, 2022

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments. The image of psychedelic drugs within medical research is changing. A psychedelic renaissance.

Life Science 105

Life Science Clinical Trials Clinical Trials Trials 105

pharmaphorum

DECEMBER 23, 2020

The capital injection will support wide-ranging plans for the new year that include several life sciences programmes in surgery, pathology and immunology, which would add to the digital ophthalmology joint venture it signed with Japan’s Santen in February. Meanwhile, the last 12 months have seen a refocusing at Onduo.

Life Science 59

Life Science Pharma Companies Clinical Research Production 59

pharmaphorum

AUGUST 31, 2021

For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. However, if history is any indication, pharma companies have been risk-averse when it comes to fully immersing itself into the expanded use of RWE in our development efforts. About the authors.

Clinical Trials 89

Clinical Trials Clinical Trials Life Science Trials 89

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. Clinical Data Pipeline for Data Review and Analyses.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

APRIL 7, 2021

With other drugs in the pipeline too, van de Winkel said the company aims to continue to break new ground with next-generation antibody-based therapies. He notes that it already has 21 partnerships with pharma companies and will aim to keep more product rights than it did in the past. Role models.

Antibody 91

Antibody Life Science Development Drugs 91

pharmaphorum

MAY 27, 2022

The adoption of digital healthcare tools in clinical research accelerated dramatically during the COVID-19 pandemic and it is expected that such tools will continue to contribute to clinical research in the future. What comes next?

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

JULY 8, 2022

Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. That is what’s exciting – as we see DCTs continue to play such a key role that they become the standard for the future of clinical research,” predicts Reites.

Clinical Trials 100

Clinical Trials Clinical Trials Trials Regulation 100

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. “The Saama Technologies, Inc. ,

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

XTalks

SEPTEMBER 5, 2023

The clinical trial landscape overall has evolved significantly with key changes in the social, ethical and regulatory environment globally with the creation of guidance by regulators with new regulatory pathways for approval of products specifically developed for diseases in LMIC and public health emergencies.

Vaccination 96

Vaccination Vaccine Development Clinical Trials 96

XTalks

AUGUST 18, 2020

The study was funded by a clinical research agreement with the NBA and the players’ union – the National Basketball Players Association (NDG) – which together, contributed over $500,000 to fund the Yale study. The results of the two tests displayed almost universal equivalency.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Cloudbyz

MAY 19, 2021

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. However, the major challenge is the newness and uncharted territory of the CGT field for service companies.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

pharmaphorum

OCTOBER 10, 2022

Such partnerships are mutually beneficial for all involved parties as pharma companies have a wealth of data, insight, and connections at their disposal, resources that can play a central role in enabling early diagnosis for the NHS and patients. Our ambition is to eliminate cancer as a cause of death.

Development 98

Development Research Marketing Life Science 98

The Pharma Data

DECEMBER 17, 2020

Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. Recro – CDMO company Recro announced David Enloe as its new president and CEO.

Development 52

Development Gene Therapy Engineer Life Science 52

XTalks

MAY 11, 2023

The need to develop points in time where patient insights can inform clinical research is really critical. Do you think there’s a difference between how large, or more established, pharma companies are trying to incorporate the patient voice versus smaller biotechs? ” It’s actually part of the process.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

pharmaphorum

DECEMBER 15, 2022

Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present online), the NHS Innovation and Life Sciences Commission Report launch took place at One Great George Street, Westminster, on 12th December 2022. The UK as a powerhouse of research.

Life Science 97

Life Science Medicine Clinical Trials Clinical Trials 97

XTalks

OCTOBER 1, 2020

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Funding in the Life Science Industry vs. Academia. In industry, things move so much faster.

Scientist 52

Scientist In-Vitro Research Life Science 52

XTalks

JANUARY 15, 2024

The field of clinical research will witness significant advancements in 2024. Read on to learn about the top 10 clinical trial trends for 2024, and be sure to explore and join upcoming webinars about clinical trials at Xtalks. Blockchain can enhance data security and compliance by creating immutable data records.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

XTalks

DECEMBER 30, 2024

Quality assurance (QA) plays a vital role across industries like life sciences, food, medical devices and healthcare. From life-saving drugs to ensuring the food we consume is safe, QAs impact is far-reaching. Background, Skills and Know-How A bachelors degree in law, life sciences or business is common.

Compliance 52

Compliance Engineer Life Science Manufacturing 52

XTalks

FEBRUARY 11, 2025

Advances in Research and Treatment Recent efforts by global pharma companies reflect a renewed commitment to childhood cancer. At the same time, pharma companies and non-profits continue expanding pediatric oncology research, while global health organizations drive collaborations to improve treatment access.

Gene Therapy 66

Gene Therapy Clinical Trials Clinical Trials Trials 66

pharmaphorum

NOVEMBER 15, 2021

.” After his 11-month stint heading the agency, Califf returned to his role as a cardiologist whilst also serving as a health policy and strategy advisor to Google’s unit life sciences unit Verily and running Duke University’s Clinical Research Institute, which he founded in 1996.

Regulation 98

Regulation Life Science Pharma Companies Drugs 98